Eleonor Tiblad

Summary

Affiliation: Karolinska University Hospital
Country: Sweden

Publications

  1. doi request reprint Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies
    Eleonor Tiblad
    Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 92:1079-85. 2013
  2. pmc Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program
    Eleonor Tiblad
    Department of Clinical Science Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 8:e70984. 2013
  3. doi request reprint Pharmacokinetics of 250 μg anti-D IgG in the third trimester of pregnancy: an observational study
    Eleonor Tiblad
    Department of Obstetrics and Gynecology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden
    Acta Obstet Gynecol Scand 91:587-92. 2012
  4. ncbi request reprint [Fetal neonatal alloimmune thrombocytopenia--underdiagnosed complication. A joint management strategy is missing]
    Eleonor Tiblad
    Kvinnokliniken, Karolinska Universitetssjukhuset Huddinge, Stockholm
    Lakartidningen 102:130-2. 2005
  5. doi request reprint Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm
    Eleonor Tiblad
    Center for Fetal Medicine, Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Fetal Diagn Ther 30:266-73. 2011
  6. doi request reprint Establishing a national program for fetoscopic guided laser occlusion for twin-to-twin transfusion syndrome in Sweden
    Sverker Ek
    Karolinska Institute, Center of Fetal Medicine, Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 91:1196-200. 2012
  7. ncbi request reprint Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10-year period
    Eleonor Tiblad
    Center for Fetal Medicine, Department of Obstetrics and Gynecology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
    Acta Obstet Gynecol Scand 82:803-6. 2003
  8. ncbi request reprint Fetal stem-cell transplantation
    Eleonor Tiblad
    Center for Fetal Medicine, Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Best Pract Res Clin Obstet Gynaecol 22:189-201. 2008

Detail Information

Publications8

  1. doi request reprint Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies
    Eleonor Tiblad
    Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 92:1079-85. 2013
    ..To analyze the timing of Rhesus D (RhD) immunization in pregnancy and the consequences for the index pregnancy and for subsequent pregnancies to be able to optimize the design of antenatal screening and prevention programs...
  2. pmc Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program
    Eleonor Tiblad
    Department of Clinical Science Intervention and Technology, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 8:e70984. 2013
    ..To estimate the incidence of RhD immunisation after implementation of first trimester non-invasive fetal RHD screening to select only RhD negative women carrying RHD positive fetuses for routine antenatal anti-D prophylaxis (RAADP)...
  3. doi request reprint Pharmacokinetics of 250 μg anti-D IgG in the third trimester of pregnancy: an observational study
    Eleonor Tiblad
    Department of Obstetrics and Gynecology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden
    Acta Obstet Gynecol Scand 91:587-92. 2012
    ..The aim of the study was to determine the kinetic profile and duration of detectable levels of anti-D...
  4. ncbi request reprint [Fetal neonatal alloimmune thrombocytopenia--underdiagnosed complication. A joint management strategy is missing]
    Eleonor Tiblad
    Kvinnokliniken, Karolinska Universitetssjukhuset Huddinge, Stockholm
    Lakartidningen 102:130-2. 2005
  5. doi request reprint Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm
    Eleonor Tiblad
    Center for Fetal Medicine, Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Fetal Diagn Ther 30:266-73. 2011
    ..The aim of the study is to compare our results with published results from larger centers and to identify areas that can be further improved...
  6. doi request reprint Establishing a national program for fetoscopic guided laser occlusion for twin-to-twin transfusion syndrome in Sweden
    Sverker Ek
    Karolinska Institute, Center of Fetal Medicine, Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 91:1196-200. 2012
    ..To describe the establishment of the fetoscopic guided laser occlusion (FLOC) technique for treatment of twin-to-twin transfusion syndrome (TTTS) and the initial results in a Swedish national center...
  7. ncbi request reprint Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10-year period
    Eleonor Tiblad
    Center for Fetal Medicine, Department of Obstetrics and Gynecology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
    Acta Obstet Gynecol Scand 82:803-6. 2003
    ..This is a descriptive study of the management and outcome of 18 cases of fetomaternal alloimmune thrombocytopenia (FMAIT) treated from 1991 to 2001...
  8. ncbi request reprint Fetal stem-cell transplantation
    Eleonor Tiblad
    Center for Fetal Medicine, Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
    Best Pract Res Clin Obstet Gynaecol 22:189-201. 2008
    ..This provides an opportunity to induce tolerance to alloantigens without the need for myeloablation, although there are possible immune barriers to foreign cells in the fetus...